SEC Tracker
Get the app

ArriVent BioPharma AVBP

ArriVent BioPharma: amends its charter or bylaws and discloses other events

Form
8-K
Filed
Period
Importance
Notable
Document
8-K
  • Amends its charter or bylaws (5.03)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when ArriVent BioPharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  2. Pacira BioSciences PCRX public float $758M, Jun 30, 2025
  3. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025
  4. Geron GERN public float $861M, Jun 30, 2025
  5. Anaptysbio ANAB public float $633M, Dec 31, 2025

Data on this page was fetched . The filing on SEC.gov is the record.